31

This study evaluated the prognostic significance of hormonal(FSH, LH, estradiol, progesterone, testosterone, AMH), immunological (VEGF, TGF-β, and IGF-1), and ultrasonographic (ovarian volume, antral follicle count, endometrial thickness) parameters in fertility restoration among women of late reproductive age with diminished ovarian reserve. Based on ROC analysis, the sensitivity and specificity of these markers were determined, providing a scientific foundation for the development of an individualized reproductive prediction model

  • Read count 31
  • Date of publication 10-06-2025
  • Main LanguageIngliz
  • Pages 171-180
English

This study evaluated the prognostic significance of hormonal(FSH, LH, estradiol, progesterone, testosterone, AMH), immunological (VEGF, TGF-β, and IGF-1), and ultrasonographic (ovarian volume, antral follicle count, endometrial thickness) parameters in fertility restoration among women of late reproductive age with diminished ovarian reserve. Based on ROC analysis, the sensitivity and specificity of these markers were determined, providing a scientific foundation for the development of an individualized reproductive prediction model

№ Name of reference
1 1.Adamyan L.V., Dementyeva V.O., Asaturova A.V. A new one-step surgical method for ovarian function activation in reproductive surgery // Obstetrics and Gynecology. –2019. –No. 3. –P. 147–151. (In Russian)2.Andreeva E.A., Khonina N.A., Pasman N.M., Chernykh E.R. Cytokines in the regulation of ovarian folliculogenesis: a literature review // Problems of Reproduction. –2017. –No. 1. –P. 8–14. (In Russian)3.Beik E.P., Syrkasheva A.G., Dolgushina N.V. Effectiveness of ART programs in women of latereproductive age // Gynecology. –2018. –Vol. 20, No. 1. –P. 109–112. (In Russian)4.Budanova M.A. Assessment of causes of decreased ovarian reserve in women of reproductive age // Modern Science. –2021. –Vol. 9. –P. 94–102. (In Russian)5.Gasyumova D.M., Melnikova M., Demidov A., Kuts E. Ovarian reserve and diagnostic methods in emergency gynecology // Global Reproduction. –2021. –No. S2. –P. 86–92. (In Russian)6.Zheleznaya A.A., Myagkikh I.I. Overcoming infertility in women of late reproductive age with diminished ovarian reserve // Medical and Social Problems of the Family. –2021. –Vol. 26, No. 3. –P. 39–45. (In Russian)7.Myagkikh I.I. Personalized approach to treating infertility in women of late reproductive age with diminished ovarian reserve // Medical and Social Problems of the Family. –2022. –Vol. 27, No. 1. –P. 37–44. (In Russian)8.Protopopova N.V., Dudakova V.N., Druzhinina E.B., Labygina A.V. IVF effectiveness in patients with low AMH levels // Doctor.Ru. –2018. –No. 10 (154). –P. 7–9. (In Russian)9.Svorova M.S., Kravchenko E.N., Makarkina L.G. et al. Ovarian reserve in patients undergoing in vitro fertilization programs // Mother and Child in Kuzbass. –2018. –No. 1. –P. 35–38. (In Russian)10.Syrkasheva A.G., Ilyina E.O., Dolgushina N.V.Infertility in women of advanced reproductive age // Gynecology. –2016. –Vol. 18, No. 3. –P. 40–43. (In Russian)11.Cakiroglu Y. et al. Ovarian reserve parameters and IVF outcomes in 510 women with poor ovarian response treated with intraovarian injectionof PRP // Aging (Albany NY). –2022; 14(6):2513–2523.12.Drakopoulos P. et al. Update on the management of poor ovarian response in IVF: from Bologna to POSEIDON // Ther Adv Reprod Health. –2020; 14:2633494120941480.13.Esteves S.C. et al. Defining low prognosis patients undergoing ART: POSEIDON criteria –the why // Ther Adv Reprod Health. –2018; 9:461.14.Fan Y. et al. Apoptosis of mural granulosa cells is increased in women with diminished ovarian reserve // J Assist Reprod Genet. –2019; 36(6):1225–1235.15.Granger E., Tal R. Anti-Müllerian Hormone and its predictive utility in assisted reproductive technologies outcomes // Clin Obstet Gynecol. –2019; 62(2):238–256.16.He Y.J. et al. Serum anti-Müllerian hormone level and its predictive value for pregnancy outcomes// J Biol Regul Homeost Agents. –2020; 34(6):2153–2157.7.Liu Y. et al. Comparison of AMH and AFC in the prediction of ovarian response: a systematic review and meta-analysis // J Ovarian Res. –2023; 16(1):117.18.Harris B.S. et al. Markers of ovarian reserve as predictors of future fertility // Fertil Steril. –2023; 119(1):99–106.19.Cakiroglu Y. et al. Effects of intraovarian injection of autologous PRP on ovarian reserve and IVF outcomes // Aging (Albany NY). –2020; 12(11):10211–10222.20.Sharara F.I. et al. A narrative review of platelet-rich plasma in reproductive medicine // J Assist Reprod Genet. –2021; 38(5):1003–1012.21.Meczekalski B. et al. Fertility in women of late reproductive age: the role of serum AMH in its assessment // J Endocrinol Invest. –2016; 39(11):1259–1265.22.Fuentes A. et al. Androgens profile in blood serum and follicular fluid of women with poor ovarian response: clinical implications // Front Endocrinol. –2019; 10:458.23.Amaral M.E.B. et al. Risk factors for inadequate response to ovarian stimulation // J Assist Reprod Genet. –2019; 36(1):19–28.24.Bala R. et al. Environment, lifestyle, and female infertility // Reprod Sci. –2021; 28(3):617–638.25.Polyzos N.P. et al. Testosterone for poor ovarian responders: lessons from physiology // Reprod Sci. –2018; 25(7):980–982.26.Rickers N.S., Sills E.S. Is autologous platelet activation the key step in ovarian therapy? // Biomedicine (Taipei). –2022; 12(4):1–8.27.Bala R. et al. Environment, lifestyle, and female infertility // Reprod Sci. –2021; 28(3):617–638.28.Nagy B. et al. Thrombocytes and platelet-rich plasma as modulators of reproduction // Int J Mol Sci. –2023; 24(24):17336.29.Fauque P. et al. ART and imprinting disorders: risk overview // Clin Epigenetics. –2020; 12(1):191.30.Cedars M.I. Managing poor ovarian response in the patient with diminished ovarian reserve // Fertil Steril. –2022; 117(4):655–656.
Waiting